X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. TTK HEALTHCARE FDC LTD./
TTK HEALTHCARE
 
P/E (TTM) x 24.0 33.3 72.3% View Chart
P/BV x 5.0 6.1 81.8% View Chart
Dividend Yield % 0.9 0.5 199.1%  

Financials

 FDC LTD.   TTK HEALTHCARE
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TTK HEALTHCARE
Mar-14
FDC LTD./
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs144663 21.6%   
Low Rs79399 19.8%   
Sales per share (Unadj.) Rs47.6535.6 8.9%  
Earnings per share (Unadj.) Rs7.615.9 47.7%  
Cash flow per share (Unadj.) Rs9.020.0 45.0%  
Dividends per share (Unadj.) Rs2.254.00 56.3%  
Dividend yield (eoy) %2.00.8 268.6%  
Book value per share (Unadj.) Rs47.5137.6 34.5%  
Shares outstanding (eoy) m177.837.77 2,288.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.31.0 235.8%   
Avg P/E ratio x14.633.3 43.9%  
P/CF ratio (eoy) x12.326.5 46.5%  
Price / Book Value ratio x2.33.9 60.6%  
Dividend payout %29.625.1 117.9%   
Avg Mkt Cap Rs m19,7844,127 479.3%   
No. of employees `000NA1.7 0.0%   
Total wages/salary Rs m1,221607 201.2%   
Avg. sales/employee Rs ThNM2,436.7-  
Avg. wages/employee Rs ThNM355.2-  
Avg. net profit/employee Rs ThNM72.5-  
INCOME DATA
Net Sales Rs m8,4594,162 203.2%  
Other income Rs m39461 643.1%   
Total revenues Rs m8,8524,223 209.6%   
Gross profit Rs m2,070197 1,050.3%  
Depreciation Rs m24932 785.8%   
Interest Rs m3130 103.7%   
Profit before tax Rs m2,184197 1,110.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m60673 831.8%   
Profit after tax Rs m1,353124 1,092.1%  
Gross profit margin %24.54.7 516.8%  
Effective tax rate %27.737.0 74.9%   
Net profit margin %16.03.0 537.4%  
BALANCE SHEET DATA
Current assets Rs m4,3551,629 267.4%   
Current liabilities Rs m1,7921,058 169.4%   
Net working cap to sales %30.313.7 220.9%  
Current ratio x2.41.5 157.9%  
Inventory Days Days4430 149.3%  
Debtors Days Days2534 73.4%  
Net fixed assets Rs m3,025556 543.8%   
Share capital Rs m17978 229.9%   
"Free" reserves Rs m8,243878 938.5%   
Net worth Rs m8,4531,069 790.5%   
Long term debt Rs m11159 6.7%   
Total assets Rs m10,5572,399 440.0%  
Interest coverage x71.47.6 942.3%   
Debt to equity ratio x00.1 0.9%  
Sales to assets ratio x0.81.7 46.2%   
Return on assets %13.16.4 204.5%  
Return on equity %16.011.6 138.2%  
Return on capital %23.518.5 127.4%  
Exports to sales %13.30.8 1,683.5%   
Imports to sales %3.31.4 238.7%   
Exports (fob) Rs m1,12633 3,421.6%   
Imports (cif) Rs m28358 485.1%   
Fx inflow Rs m1,14633 3,483.6%   
Fx outflow Rs m35563 562.3%   
Net fx Rs m791-30 -2,610.8%   
CASH FLOW
From Operations Rs m1,485127 1,172.9%  
From Investments Rs m-620-146 424.3%  
From Financial Activity Rs m-75322 -3,436.1%  
Net Cashflow Rs m1133 4,512.0%  

Share Holding

Indian Promoters % 68.9 65.4 105.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 3.7 127.0%  
FIIs % 7.5 5.2 144.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 25.8 73.6%  
Shareholders   23,730 12,723 186.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   FULFORD INDIA  SUVEN LIFE  CIPLA  ELDER PHARMA  VENUS REMEDIES  

Compare FDC LTD. With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jan 23, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - UNICHEM LAB COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS